Endonovo Therapeutics Inc (ENDV): https://www.otcmarkets.com/stock/ENDV/in...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Thursday, 06/22/2017 8:52:29 PM

Thursday, June 22, 2017 8:52:29 PM

https://www.otcmarkets.com/stock/ENDV/insider-transactions

156 Buys on the open market the last 6 months 0 sells.

The insider Buying frenzy occurs frequently.

I believe ENDV has more potential than any other stock on any exchange from these levels.

ENDV will change the way medicine and the health care industry work.

ENDV is about to create some serious wealth for its shareholders. New Multi Millionaires will be created from being a significant ENDV Shareholder.

http://microcapspeculators.com/news/small-biotechs-may-beat-silicon-valley-tech-titans-and-big-pharma-in-the-bioelectronic-medicine-race/

http://analysis.secfilings.com/articles/74-endonovo-at-the-intersection-of-stem-cells-and-biologics-for-next-generation-therapeutics

http://analysis.secfilings.com/articles/65-endonovo-establishing-its-footprint-in-non-invasive-bioelectronic-medicine-space

$ENDV

Keep Last Read

Next 10 Prev Next

Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/02/2024 10:23:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:30:14 PM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 12/29/2023 08:20:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:08:41 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 05:21:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 10:03:32 AM
Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 08/25/2023 11:04:33 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/21/2023 09:16:04 PM

InvestorsHub NewsWire

Only $200 per official company press release!